- Home
- GLP-1 Centre
- Fake Ozempic pens
Reviewed by Dr Sarah Mitchell, PhD · Editorial Board
Fake Ozempic pens — UK identifiers
Counterfeit Ozempic pens have been a recurring UK safety issue. The MHRA has issued repeated alerts about fake pens reaching UK patients via unlicensed supply. This page covers genuine-product identifiers, common counterfeit patterns, and what to do if your pen looks wrong.
Why counterfeit Ozempic exists in the UK
Three factors create the market for counterfeit Ozempic:
- Sustained demand outstrips lawful supply. Off-label weight-loss prescribing has pulled Ozempic supply away from diabetes patients.
- High unit price. Falsification is profitable.
- Online supply chains. Buyers pushed away from UK pharmacies (waiting lists, eligibility criteria, cost) end up on online routes that don’t go through a real prescriber.
Genuine Ozempic — what to check
- Outer carton: Novo Nordisk branding, matching dose strength clearly printed, tamper-evident seal intact, matching batch number and expiry on box and pen.
- PIL: A UK English Patient Information Leaflet should be inside the carton.
- Pen body: Recognisable Novo Nordisk pen design, dose dial that clicks audibly, clear printing, ink that doesn’t smudge under finger pressure.
- Cartridge: Clear, colourless solution without particulates.
Counterfeit patterns the MHRA has documented
- Pens repackaged into non-Novo cartons.
- Missing PIL or PIL in a non-English language only.
- Mismatched batch numbers between box and pen.
- Pens with a different mechanism — sometimes containing insulin or another substance instead of semaglutide. This is an acute safety risk for non-diabetic users.
- Counterfeit cartons that look correct at a glance but show poor printing detail on close inspection.
What to do if you think your pen is fake
- Don’t inject.
- Photograph the carton, pen, and PIL.
- Contact your dispensing pharmacy if it’s a UK-registered pharmacy that supplied it.
- Report via Yellow Card and the GOV.UK report-a-problem form. Include the URL, payment details, and shipping route if obtained via an unlawful chain.
- If you have injected, contact NHS 111 or your prescriber. Watch for unusual reactions, infection at the injection site, and especially for hypoglycaemia (if the pen contained insulin rather than semaglutide).
Red-flag claims
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“Cheap Ozempic — UK shipping, no diabetes diagnosis needed”
‘No diabetes diagnosis needed’ removes the prescriber from the chain, which is what makes supply lawful. This is exactly the route counterfeit Ozempic has used to reach UK patients.
“Ozempic from our partner pharmacy in Turkey/Germany/India”
Cross-border supply has been the main counterfeit-Ozempic supply route flagged by MHRA. Country of origin doesn't validate it.
“Bulk Ozempic deal — 6 months supply”
Bulk consumer supply is a counterfeit signal. Real pharmacies dispense per prescription.
“Ozempic at the same price as Wegovy”
Pricing patterns matter. Significantly underpriced supply during a shortage is one of the strongest counterfeit signals.
Sources & further reading
- MHRA Drug Safety Update — gov.uk
- Report a problem with a medicine or medical device — gov.uk
- Yellow Card — yellowcard.mhra.gov.uk
- Action Fraud — actionfraud.police.uk
- MHRA — gov.uk